Implementing a digital solution to support cancer patients with mental health co-morbidities: A need for ai-driven first-line support strategies
Abstract
Cancer remains a leading cause of morbidity and mortality worldwide, imposing significant physical, emotional, and economic burdens on patients and healthcare systems. Beyond the direct physiological challenges of treatment, individuals with cancer often experience profound psychosocial distress, including symptoms of depression and anxiety, which can hinder treatment adherence and coping capacity. Despite evidence that psychosocial interventions can enhance overall well-being and sometimes even survival rates, integration of mental health into oncology care faces obstacles such as workforce shortages, stigma, and geographical barriers. To strengthen the scientific contribution of this work, we now (i) clarify that the paper presents a mixed methods development evaluation protocol rather than a purely conceptual proposal, and (ii) summarize preliminary feasibility data collected in two European cancer centers (n = 96; see Section 5). Based upon the feasibility study, this paper proposes-empirically based pilots- to measure a digital mental health triage solution underpinned by artificial intelligence (AI). By embedding routine psychosocial screening into oncology workflows, patients are stratified into low, moderate or high-risk tiers. Low and moderate tiers receive AI guided self-management resources; high-risk patients are referred rapidly to specialist care. Psychological distress was assessed at baseline and after four weeks using the 51-item Empowerment for Participation mini assessment (EFP Mini), highly correlated with both GAD-7 and PHQ-9. Group 1 (Cohort & Self-assessment only) achieved a modest but statistically significant reduction in total distress scores (Δ = –28.8 ± 54.6; 95% CI [–54.36, –3.24]; t(19) = –2.36; p = 0.029), Group 2 (self-assessment with Ai support) showed a non-significant trend toward improvement (Δ = –22.8 ± 39.3; 95% CI [–50.90, 5.30]; t(9) = –1.84; p = 0.10), and Group 3 (self-assessment with the blended AI + human coaching arm yielded a large, clinically meaningful decrease (Δ = –121.7 ± 55.3; 95% CI [–161.26, –82.14]; t(9) = –6.96; p < 0.001), with a one-way ANOVA confirming significant differences across groups (F(2, 37) = 12.79; p < 0.001). Potential benefits, implementation challenges and regulatory implications-including the forthcoming EU AI Act-are critically examined. This paper explores the methodological considerations, potential benefits, and implementation challenges associated with an AI-driven mental health triage system in oncology. Future directions include long-term evaluations of effectiveness, cost-benefit analyses, and culturally sensitive adaptations across diverse healthcare settings.
Copyright (c) 2026 Clive Michelsen
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. A Cancer Journal for Clinicians. 2021; 71(3): 209–249. doi: 10.3322/caac.21660
2. Wu Z, Xia F, Lin R. Global burden of cancer and associated risk factors in 204 countries and territories, 1980–2021: A systematic analysis for the GBD 2021. Journal of Hematology & Oncology. 2024, 17(1); 119. doi: 10.1186/s13045-024-01640-8
3. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. A Cancer Journal for Clinicians. 2022; 72(1): 7–33. doi: 10.3322/caac.21708
4. Smith HR. Depression in cancer patients: Pathogenesis, implications and treatment. Oncology Letters. 2015; 9(4): 1509–1514. doi: 10.3892/ol.2015.2944
5. Zainal NZ, Booth S, Huppert FA. The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: A meta-analysis. Psychooncology. 2013; 22(7): 1457–1465. doi: 10.1002/pon.3171
6. Johannsen M, Farver I, Beck N, Zachariae R. The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013 Apr;138(3):675–90. doi: 10.1007/s10549-013-2503-4
7. Caruso R, GiuliaNanni M, Riba MB, Sabato S, Grassi L. Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review. Curr Psychiatry Rep. 2017 Jun;19(6):33. doi: 10.1007/s11920-017-0785-7. PMID: 28488207; PMCID: PMC5423924.
8. Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer. BMJ. 2018; 361: k1415. doi: 10.1136/bmj.k1415
9. Andersen BL, Yang HC, Farrar WB, et al. Psychological intervention improves survival for breast cancer patients: A randomized clinical trial. Cancer. 2008; 113(12): 3450–3458. doi: 10.1002/cncr.23969
10. Health and Human Services Department, National Institutes of Health. Fact Sheet, National Cancer Institute;3.17. Psychological Stress and Cancer: Questions and Answers. 2021. Available online: https://www.govinfo.gov/app/details/GOVPUB-HE20_3000-PURL-LPS101256.
11. Charlton M, Schlichting J, Chioreso C, et al. Challenges of Rural Cancer Care in the United States. Oncology (Williston Park). 2015; 29(9):633–40.
12. Corrigan PW, Watson AC. Understanding the impact of stigma on people with mental illness. World Psychiatry. 2002; 1(1): 16–20.
13. Crockett MA, Núñez D, Martínez P, et al. Interventions to Reduce Mental Health Stigma in Young People. JAMA Network Open. 2025; 8(1): e2454730. doi: 10.1001/jamanetworkopen.2024.54730
14. Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin. 2018 Mar;68(2):153–165. doi: 10.3322/caac.21443
15. Carlson LE, Zelinski EL, Toivonen KI, et al. Prevalence of psychosocial distress in cancer patients across 55 North American cancer centers. Journal Of Psychosocial Oncology. 2019; 37(1): 5–21. doi: 10.1080/07347332.2018.1521490
16. Naslund JA, Marsch LA, McHugo GJ, et al. Emerging mHealth and eHealth interventions for serious mental illness: A review of the literature. Journal of Mental Health. 2017; 26(4): 321–332. doi: 10.3109/09638237.2015.1019054
17. Biagianti B, Hidalgo-Mazzei D, Meyer N. Developing digital interventions for people living with serious mental illness: perspectives from three mHealth studies. Evidence Based Mental Health. 2017; 20(4): 98–101. doi: 10.1136/eb-2017-102765
18. Greenway, FT, Weal M, Palmer-Cooper EC. Hybrid mHealth care: Patient perspectives of blended treatments for psychosis. A systematic review. Schizophrenia Research. 2024; 274: 1–10. doi: 10.1016/j.schres.2024.08.017
19. Galway K, Black A, Cantwell M, et al. Psychosocial interventions to improve quality of life and emotional well-being for recently diagnosed cancer patients. Cochrane Database of Systematic Reviews. 2012; 2012(11): CD007064. doi: 10.1002/14651858.cd007064.pub2
20. Faller H, Schuler M, Richard M, et al. Effects of psycho-oncological interventions on emotional distress and quality of life in adult patients with cancer: Systematic review and meta-analysis. Journal of Clinical Oncology. 2013; 31(6): 782–793. doi: 10.1200/JCO.2011.40.8922
21. Mitchell AJ, Ferguson DW, Gill J, et al. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: A systematic review and meta-analysis. Lancet Oncol. 2013; 14(8): 721-732. doi: 10.1016/s1470-2045(13)70244-4
22. Forbes H, Carreira H, Funston G, et al. Early, medium and long-term mental health in cancer survivors compared with cancer-free comparators: matched cohort study using linked UK electronic health records. ClinicalMedicine. 2024; 76: 102826. doi: 10.1016/j.eclinm.2024.102826
23. Osmani V, Hörner L, Klug SJ, et al. Prevalence and risk of psychological distress, anxiety and depression in adolescent and young adult (AYA) cancer survivors: A systematic review and meta‐analysis. Cancer Medicine. 2023; 12(17): 18354–18367. doi: 10.1002/cam4.6435
24. Götze H, Friedrich M, Taubenheim S, et al. Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis. Supportive Care in Cancer. 2019; 28(1): 211–220. doi: 10.1007/s00520-019-04805-1
25. Roth AJ, Kornblith AB, Batel-Copel L, et al. Rapid screening for psychologic distress in men with prostate carcinoma: A pilot study. Cancer. 1998; 82(10): 1904–1908. doi: 10.1002/(sici)1097-0142(19980515)82:10<1904::aid-cncr13>3.0.co;2-x
26. Michelsen C, Kjellgren A. A perspective on developing an AI-driven digital triage platform for chronic disease mental health: insights and potential from My-E-Health. AIMS Medical Science, 2025, 12(4): 312–324. doi: 10.3934/medsci.2025022
27. Technical Committee ISO/TC 210. ISO 14971:2019. Medical devices – Application of risk management to medical devices. Available online: https://www.iso.org/standard/72704.html
28. Park H, Oh S, Noh Y, et al. Heart Rate Variability as a Marker of Distress and Recovery: The Effect of Brief Supportive Expressive Group Therapy With Mindfulness in Cancer Patients. Integr Cancer Ther. 2018; 17(3): 825–831. doi: 10.1177/1534735418756192
29. Thunström A, Ali L, Krage Carlsen H, et al. Behavior Emotion Therapy System and You: Co-Design and Evaluation of a Mental Health Chatbot and Digital Human for Mild to Moderate Anxiety in Healthy Participants. JMIR Formative Research. 2025; 9: e66163. doi: 10.2196/66163
30. Michelsen C, Kjellgren A. The Effectiveness of Web-Based Psychotherapy to Treat and Prevent Burnout: Controlled Trial, JMIR Formative Research. 2022; 6(8): e39129. doi: 10.2196/39129
31. Van Liew JR, Christensen AJ, de Moor JS. Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research. Journal of Cancer Survivorship. 2014; 8(3):521–31. doi: 10.1007/s11764-014-0374-2
32. Goel I, Bhaskar Y, Kumar N, et al. Role of AI in empowering and redefining the oncology care landscape: perspective from a developing nation. Front. Digit. Health .2025; 7: 1550407. doi: 10.3389/fdgth.2025.1550407
33. Malhotra C, Bundoc F, Chaudhry I, et al; COMPASS study group. A prospective cohort study assessing aggressive interventions at the end-of-life among patients with solid metastatic cancer. BMC Palliat Care. 2022; 21(1): 73. doi: 10.1186/s12904-022-00970-z
34. Kumar A, Goel S, Chaudhary A, et al. Artificial Intelligence-Based Wearable Sensing Technologies for the Management of Cancer, Diabetes, and COVID-19. Biosensors (Basel). 2025; 15(11): 756. doi: 10.3390/bios15110756
35. Chen IY, Joshi S, Ghassemi M. Treating health disparities with artificial intelligence. Nature Medicine. 2020; 26(1): 16–17. doi: 10.1038/s41591-019-0649-2
36. Nandagopal S. Beyond Static Products: Rethinking Regulatory Hurdles and "Significant Change" in Digital Mental Health Technologies Across India, the EU/UK, and the United States; 2025. doi: 10.2139/ssrn.5824142
37. Luxton DD, Nelson EL, Maheu MM, et al. A practitioner's guide to telemental health: How to conduct legal, ethical, and evidence-based telepractice. American Psychological Association; 2016. doi: 10.1037/14938-000
38. Arman M, Ranheim A, Rydenlund K, et al. The Nordic Tradition of Caring Science: The Works of Three Theorists. Nursing Science Quarterly. 2015; 28(4): 288–96. doi: 10.1177/0894318415599220
39. Yuan B, Kabir M, He JC, et al. Development of Machine Learning Systems to Predict Cancer-Related Symptoms With Validation Across a Health Care System. JCO Clin Cancer Inform. 2025; 9: e2500073. doi: 10.1200/CCI-25-00073
40. Topol EJ. High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine. 2019; 25(1): 44–56. doi: 10.1038/s41591-018-0300-7
41. Triantafyllidis A, Tsanas A. Applications of machine learning in real-life digital health interventions: Review of the literature. Journal of Medical Internet Research. 2019; 21(4): e12286. doi: 10.2196/12286
42. Torous J, Lipschitz J, Ng M, et al. Dropout rates in clinical trials of smartphone apps for depressive symptoms: A systematic review and meta-analysis. Journal of Affective Disorders. 2020; 263: 413–419. doi: 10.1016/j.jad.2019.11.167
43. Vo AT, Gustafson DL. Telepharmacy in oncology care: A scoping review. J Telemed Telecare. 2022; 29(3):165–176. doi: 10.1177/1357633X20975257
44. Rajkomar A, Hardt M, Howell MD, et al. Ensuring fairness in machine learning to advance health equity. Annals of Internal Medicine. 2018; 169(12): 866–872. doi: 10.7326/M18-19
45. Sieverink F, Kelders S, Poel M, van Gemert-Pijnen L. Opening the Black Box of Electronic Health: Collecting, Analyzing, and Interpreting Log Data. JMIR Res Protoc. 2017; 6(8):e156. doi: 10.2196/resprot.6452
46. Kichloo A, Albosta M, Dettloff K, et al. Telemedicine, the current COVID-19 pandemic and the future: A narrative review and perspectives moving forward in the USA. Fam Medicine Community Health. 2020; 8(3): e000530. doi: 10.1136/fmch-2020-000530
47. Insel TR. Digital phenotyping: Technology for a new science of behavior. JAMA. 2017; 318(13): 1215–1216. doi: 10.1001/jama.2017.11295
48. Schueller SM, Torous J. Scaling evidence-based treatments through digital mental health. Am Psychol. 202; 75(8):1093–1104. doi: 10.1037/amp0000654
